A low-carbon version of a triple combination pMDI inhaler indicated for adults with moderate-to-severe COPD has been approved by the MHRA.

Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.

The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...

The clinical trial for the potential vaccine, VLA15, began in August 2022. Stage 3 trials got underway in late 2023, ...

The pharma company said it expects more approvals through the year following positive results from a Phase 3 trial.

NBCC: The company has successfully sold 446 residential units at Aspire Silicon City in Noida through an e-auction, generating Rs 1,468 crore in sales. Additionally, it will receive a marketing fee of ...

Children with asthma experienced fewer exacerbations and better control with dupilumab regardless of the duration of their ...